| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX16 ERCC2 ABCA4 PSMC1 KIF12 CHD7 MORC4 ABCA10 ABCA6 MLH1 ACIN1 MACF1 DNAH5 HSP90AA1 | 3.59e-05 | 441 | 175 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | chromatin binding | KAT5 POLR2A KDM3B RCC1 CITED1 CHD7 TSPYL1 SIRT6 BAP1 TRIM28 ASXL3 MLH1 ANKRD17 SMARCC2 SETD7 LEF1 OBI1 CBX2 | 9.03e-05 | 739 | 175 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX16 ERCC2 ABCA4 MYO9A PSMC1 KIF12 CHD7 CPOX MORC4 ABCA10 ABCA6 MLH1 ACIN1 MACF1 DNAH5 HSP90AA1 | 1.04e-04 | 614 | 175 | 16 | GO:0140657 |
| GeneOntologyBiologicalProcess | GTP biosynthetic process | 3.08e-06 | 13 | 171 | 4 | GO:0006183 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.30e-05 | 37 | 171 | 5 | GO:0042178 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | RELN DENND4A RIPOR2 MYO9A ITSN1 ARHGEF17 ITPKB NRP1 PLEKHG4B LRP4 AKAP13 ARHGAP18 | 2.29e-05 | 333 | 171 | 12 | GO:0051056 |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 3.04e-05 | 8 | 171 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | developmental cell growth | CPNE9 PI16 SIRT6 NRP1 KMT2D PPP3CB EIF2B2 MACF1 COL14A1 AKAP13 TMEM108 | 4.45e-05 | 301 | 171 | 11 | GO:0048588 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | NPHS1 RELN RIPOR2 KAT5 ITSN1 SIRT6 AMIGO1 NRP1 PTK2B PPP3CB PPP3CC TRIM28 EIF2B2 MIB1 LRP4 MACF1 TRPV4 KDR RIMBP2 SHCBP1L NME1 NME2 MAP2K7 PLK4 HSP90AA1 HTT | 6.03e-05 | 1366 | 171 | 26 | GO:0051130 |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 6.44e-05 | 10 | 171 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | UTP biosynthetic process | 8.80e-05 | 11 | 171 | 3 | GO:0006228 | |
| GeneOntologyBiologicalProcess | GTP metabolic process | 9.21e-05 | 29 | 171 | 4 | GO:0046039 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | ERCC2 KAT5 SIRT6 PTK2B RIF1 WIZ TRIM28 MLH1 SMARCC2 MAP2K7 HSP90AA1 | 1.10e-04 | 333 | 171 | 11 | GO:0051054 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.17e-04 | 12 | 171 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | hepatocyte growth factor receptor signaling pathway | 1.17e-04 | 12 | 171 | 3 | GO:0048012 | |
| GeneOntologyBiologicalProcess | UTP metabolic process | 1.51e-04 | 13 | 171 | 3 | GO:0046051 | |
| GeneOntologyBiologicalProcess | neuron development | GABRB2 FAT4 RELN RIPOR2 CPNE9 MYO9A ITSN1 PCARE AMIGO1 CNTN6 USP21 NRP1 PLEKHG4B PTK2B PPP3CB HMCN2 EIF2B2 PAK2 LRP4 MACF1 TRPV4 KDR TMEM108 NME1 NME2 HTT | 1.83e-04 | 1463 | 171 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | chromosome organization | PDS5B ERCC2 RIPOR2 KAT5 SIRT6 RIF1 MEIOC TRIM28 CENPI MLH1 ACIN1 SMARCC2 SHCBP1L MAP2K7 SYCE1 HSP90AA1 | 1.96e-04 | 686 | 171 | 16 | GO:0051276 |
| GeneOntologyBiologicalProcess | germline cell cycle switching, mitotic to meiotic cell cycle | 2.04e-04 | 3 | 171 | 2 | GO:0051729 | |
| GeneOntologyBiologicalProcess | CTP biosynthetic process | 2.37e-04 | 15 | 171 | 3 | GO:0006241 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 2.43e-04 | 37 | 171 | 4 | GO:0042537 | |
| Domain | NDP_KINASES | 6.19e-05 | 9 | 172 | 3 | PS00469 | |
| Domain | NDK | 8.78e-05 | 10 | 172 | 3 | SM00562 | |
| Domain | NDK | 8.78e-05 | 10 | 172 | 3 | PF00334 | |
| Domain | ABC_A | 1.59e-04 | 12 | 172 | 3 | IPR026082 | |
| Domain | Nucleoside_diP_kinase | 1.59e-04 | 12 | 172 | 3 | IPR001564 | |
| Domain | Chromo/shadow_dom | 2.31e-04 | 33 | 172 | 4 | IPR000953 | |
| Domain | CHROMO | 2.31e-04 | 33 | 172 | 4 | SM00298 | |
| Domain | - | 5.00e-04 | 4 | 172 | 2 | 3.90.1460.10 | |
| Domain | Aldehyde_DH_NAD(P) | 5.00e-04 | 4 | 172 | 2 | IPR012394 | |
| Domain | GTF2I | 5.00e-04 | 4 | 172 | 2 | PS51139 | |
| Domain | GTF2I | 5.00e-04 | 4 | 172 | 2 | PF02946 | |
| Domain | GTF2I | 5.00e-04 | 4 | 172 | 2 | IPR004212 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 7.70e-06 | 15 | 126 | 4 | MM1387 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.32e-05 | 17 | 126 | 4 | M5940 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.75e-05 | 103 | 126 | 7 | MM14752 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 5.10e-05 | 74 | 126 | 6 | M160 | |
| Pathway | REACTOME_DRUG_ADME | 5.40e-05 | 109 | 126 | 7 | M45012 | |
| Pathway | WP_GLUCURONIDATION | 6.65e-05 | 25 | 126 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 6.65e-05 | 25 | 126 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 7.81e-05 | 26 | 126 | 4 | M39404 | |
| Pathway | REACTOME_DRUG_ADME | 9.43e-05 | 119 | 126 | 7 | MM15692 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 2.29e-04 | 34 | 126 | 4 | MM1399 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.36e-04 | 14 | 126 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 3.59e-04 | 16 | 126 | 3 | M16498 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 3.93e-04 | 39 | 126 | 4 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 3.93e-04 | 39 | 126 | 4 | M1908 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.93e-04 | 39 | 126 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 4.77e-04 | 41 | 126 | 4 | M7399 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MPP3 FLNC ERCC2 HIVEP2 IMPDH1 POLR2A ZBTB4 KDM3B APEH IRS1 MLXIP SPPL2B BAP1 GGT7 ZCCHC14 FAT1 MGAT1 KMT2D OVOL1 WIZ TRIM28 DIP2C LRP4 AKAP13 CEP131 ZC3H7B MED13 HTT CBX2 | 4.38e-13 | 1105 | 177 | 29 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GAPVD1 DENND4A HIVEP2 MYO9A EXPH5 KDM3B IRS1 MLXIP ARHGEF17 MELK ITPKB ZCCHC14 PTK2B CASKIN2 TRIM9 KIAA1217 ANKRD17 MACF1 AKAP13 CEP131 MAP2K7 PLK4 OBI1 WNK3 | 1.61e-11 | 861 | 177 | 24 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DHX16 PDS5B FILIP1 GAPVD1 ITSN1 POLR2A KDM3B RCC1 CHD7 GPATCH8 BAP1 RIF1 KMT2D MTAP GTF3C1 USP42 TRIM28 NFIC ACIN1 ANKRD17 SMARCC2 MED13 | 8.37e-11 | 774 | 177 | 22 | 15302935 |
| Pubmed | FLNC RIPOR2 HIVEP2 MYO9A EXPH5 ITSN1 NCKAP5 NEB RIF1 KIAA1549L TRIM28 PAK2 ANKRD17 MACF1 AKAP13 OBI1 HSP90AA1 | 6.01e-10 | 486 | 177 | 17 | 20936779 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DHX16 FLNC GAPVD1 KAT5 POLR2A RCC1 CPOX BAP1 RIF1 RBM22 KMT2D WIZ GTF3C1 NFIC ANKRD17 SMARCC2 SETD7 NME1 OBI1 HSP90AA1 | 1.78e-08 | 857 | 177 | 20 | 25609649 |
| Pubmed | FLNC GAPVD1 PSMC1 KDM3B APEH RCC1 GPATCH8 NUFIP2 PAK2 ACIN1 SMARCC2 SETD7 NME1 NME2 | 2.01e-08 | 399 | 177 | 14 | 35987950 | |
| Pubmed | CEP85 POLR2A PSMC1 RCC1 HID1 CCDC77 PTPDC1 RIF1 KMT2D PPP3CB PPP3CC WIZ CASKIN2 NUFIP2 MIB1 MLH1 CEP131 SETD7 ALDH3A2 PLK4 HSP90AA1 CBX2 | 2.20e-08 | 1049 | 177 | 22 | 27880917 | |
| Pubmed | GAPVD1 EXPH5 ITSN1 CCDC77 MEIOC CASKIN2 TRIM9 KIAA1217 NUFIP2 MACF1 ALDH3A2 | 1.21e-07 | 263 | 177 | 11 | 34702444 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 8270257 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX16 PDS5B FLNC RELN REXO4 KAT5 POLR2A RCC1 PODXL2 CHD7 GPATCH8 RBM22 WIZ GTF3C1 USP42 TRIM28 ACIN1 SMARCC2 MACF1 NME1 HSP90AA1 | 1.72e-07 | 1082 | 177 | 21 | 38697112 |
| Pubmed | GAPVD1 RCC1 CHD7 MORC4 BAP1 KMT2D WIZ GTF3C1 ANKRD17 CEP131 NME1 NME2 OBI1 | 2.62e-07 | 418 | 177 | 13 | 34709266 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GAPVD1 POLR2A KDM3B TACC2 RIF1 WIZ TRIM9 TRIM28 KIAA1217 NUFIP2 MLH1 PAK2 ACIN1 ANKRD17 MACF1 NME1 NME2 ALDH3A2 HSP90AA1 | 3.42e-07 | 934 | 177 | 19 | 33916271 |
| Pubmed | PDS5B FLNC DENND4A PCDHGA6 ITSN1 RCC1 CPOX CCDC77 NEB ADAMTS12 RBM22 GTF2IRD2B MTAP GTF3C1 GTF2IRD2 ACIN1 SMARCC2 MACF1 KDR NME1 NME2 OBI1 MED13 HSP90AA1 | 3.53e-07 | 1442 | 177 | 24 | 35575683 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CEP85 MYO9A AAMDC ITSN1 TBC1D2B TACC2 CHD7 MORC4 RBM22 KIAA1217 MACF1 CEP131 NME2 ALDH3A2 OBI1 | 3.89e-07 | 588 | 177 | 15 | 38580884 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DHX16 PDS5B REXO4 KDM3B CHD7 GPATCH8 BAP1 RIF1 WIZ GTF3C1 NFIC MLH1 SMARCC2 CBX2 TRMT61A | 5.92e-07 | 608 | 177 | 15 | 36089195 |
| Pubmed | SOX6 RELN CEP85 HIVEP2 ITSN1 ZBTB4 PSMC1 APEH NCKAP5 ARMCX4 RBM22 PPP3CB WIZ TRIM9 MIB1 PPP1R16B PAK2 LRP4 ZNF624 MACF1 MED13 HSP90AA1 | 7.13e-07 | 1285 | 177 | 22 | 35914814 | |
| Pubmed | FLNC POLR2A PSMC1 RCC1 CPOX GTF3C1 MLH1 PAK2 ANKRD17 SMARCC2 NME2 HSP90AA1 | 1.48e-06 | 411 | 177 | 12 | 36652389 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | PDS5B POLR2A KDM3B RIF1 KMT2D WIZ GTF3C1 NFIC NUFIP2 ACIN1 SMARCC2 | 1.57e-06 | 341 | 177 | 11 | 32971831 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 PDS5B FLNC REXO4 MYO9A POLR2A PSMC1 RCC1 CHD7 MELK RIF1 RBM22 GTF3C1 TRIM28 MIB1 MLH1 ACIN1 ANKRD17 SMARCC2 MACF1 AKAP13 HSP90AA1 | 1.66e-06 | 1353 | 177 | 22 | 29467282 |
| Pubmed | ERCC2 REXO4 KAT5 IMPDH1 POLR2A PSMC1 CHD7 TSPYL1 GPATCH8 RIF1 RBM22 MGAT1 PPP3CC WIZ NUFIP2 MLH1 ANKRD17 MACF1 CEP131 NME2 ZC3H7B ALDH3A2 MED13 | 2.45e-06 | 1497 | 177 | 23 | 31527615 | |
| Pubmed | 3.48e-06 | 234 | 177 | 9 | 36243803 | ||
| Pubmed | GAPVD1 TBC1D2B KDM3B MELK BAP1 CASKIN2 TRIM9 MIB1 LRP4 ANKRD17 SETD7 ZC3H7B MED13 | 3.58e-06 | 529 | 177 | 13 | 14621295 | |
| Pubmed | SOX6 REXO4 CEP85 KAT5 PSMC1 CHD7 GPATCH8 MORC4 BAP1 RIF1 FAT1 KMT2D WIZ GTF3C1 TRIM9 NFIC ANKRD17 SMARCC2 CEP131 NME1 NME2 CBX2 | 4.00e-06 | 1429 | 177 | 22 | 35140242 | |
| Pubmed | 4.47e-06 | 7 | 177 | 3 | 26074487 | ||
| Pubmed | DHX16 PDS5B ERCC2 KAT5 POLR2A KDM3B RCC1 GPATCH8 SIRT6 RIF1 GTF3C1 TRIM28 NFIC PAK2 ACIN1 SMARCC2 MED13 HSP90AA1 | 4.77e-06 | 1014 | 177 | 18 | 32416067 | |
| Pubmed | GAPVD1 CEP85 POLR2A KDM3B RCC1 KMT2D WIZ GTF3C1 TRIM28 NUFIP2 PAK2 ACIN1 HTT | 5.33e-06 | 549 | 177 | 13 | 38280479 | |
| Pubmed | FAT4 ABCA4 KDM3B MUC16 CHD7 MORC4 NEB ITPKB RBM22 KMT2D ASXL3 MIB1 ANKRD17 SMARCC2 | 5.49e-06 | 638 | 177 | 14 | 31182584 | |
| Pubmed | 7.12e-06 | 8 | 177 | 3 | 32093886 | ||
| Pubmed | 7.12e-06 | 8 | 177 | 3 | 26037503 | ||
| Pubmed | DHX16 PDS5B FLNC GAPVD1 REXO4 POLR2A CHD7 RIF1 GTF3C1 NUFIP2 ACIN1 ANKRD17 SMARCC2 MACF1 | 7.14e-06 | 653 | 177 | 14 | 22586326 | |
| Pubmed | DHX16 PDS5B RIPOR2 GPATCH8 MLXIP ARHGEF17 ZCCHC14 NUFIP2 ACIN1 MACF1 RIMBP2 | 8.47e-06 | 407 | 177 | 11 | 12693553 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GAPVD1 POLR2A PSMC1 RCC1 GPATCH8 RIF1 GTF3C1 TRIM28 ACIN1 HSP90AA1 | 8.63e-06 | 332 | 177 | 10 | 32786267 |
| Pubmed | 8.97e-06 | 94 | 177 | 6 | 35122331 | ||
| Pubmed | 1.04e-05 | 268 | 177 | 9 | 33640491 | ||
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | AAMDC POLR2A NME2P1 CHD7 MSI1 RBM22 PPP3CB WIZ NUFIP2 PAK2 HTT | 1.11e-05 | 419 | 177 | 11 | 33001583 |
| Pubmed | RCC1 TACC2 ZXDA RIF1 GTF3C1 TRIM28 NUFIP2 PAK2 ACIN1 AKAP13 CEP131 OBI1 | 1.15e-05 | 503 | 177 | 12 | 16964243 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.36e-05 | 101 | 177 | 6 | 24613305 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.40e-05 | 351 | 177 | 10 | 38297188 | |
| Pubmed | ERCC2 RIPOR2 AAMDC PKD1L1 TACC2 GPATCH8 SIRT6 CNTN6 ZCCHC14 GTF2IRD2B FAT1 MGAT1 CRYZ ZNF28 MLH1 COL14A1 NME2 MED13 CBX2 | 1.54e-05 | 1215 | 177 | 19 | 15146197 | |
| Pubmed | DHX16 FLNC RELN ACAA1 TRIM28 KIAA1217 MLH1 ACIN1 MACF1 HSP90AA1 | 1.74e-05 | 360 | 177 | 10 | 33111431 | |
| Pubmed | 1.83e-05 | 31 | 177 | 4 | 32245826 | ||
| Pubmed | 1.88e-05 | 107 | 177 | 6 | 30995489 | ||
| Pubmed | 2.08e-05 | 11 | 177 | 3 | 7713516 | ||
| Pubmed | 2.16e-05 | 225 | 177 | 8 | 12168954 | ||
| Pubmed | PSMC1 TSPYL1 RIF1 GTF3C1 TRIM28 NFIC CENPI MLH1 SMARCC2 MED13 CBX2 | 2.28e-05 | 453 | 177 | 11 | 29656893 | |
| Pubmed | DHX16 REXO4 CEP85 IMPDH1 RCC1 CHD7 MSI1 CCDC77 NRP1 RIF1 CRYZ NUFIP2 ACIN1 ANKRD17 SMARCC2 COL14A1 CEP131 NME1 CBX2 TRMT61A | 2.45e-05 | 1371 | 177 | 20 | 36244648 | |
| Pubmed | GAPVD1 ITSN1 POLR2A KDM3B CHD7 GPATCH8 ZNF317 MELK GGT7 ZCCHC14 SYTL4 NUFIP2 AKAP13 CEP131 | 2.57e-05 | 733 | 177 | 14 | 34672954 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34463336 | ||
| Pubmed | Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. | 2.58e-05 | 2 | 177 | 2 | 2509941 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 29777301 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 31358734 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 15249197 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 7488060 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 8245015 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28475860 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 30657779 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26086043 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34370553 | ||
| Pubmed | Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma. | 2.58e-05 | 2 | 177 | 2 | 35945149 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 36443618 | ||
| Pubmed | The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. | 2.58e-05 | 2 | 177 | 2 | 32392889 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 18757501 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 33674626 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 11333271 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28555636 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 30027561 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12200143 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21085602 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23685409 | ||
| Pubmed | Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. | 2.58e-05 | 2 | 177 | 2 | 35259022 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12153400 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12007505 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28786706 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12972261 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 11166270 | ||
| Pubmed | Interactions between NRP1 and VEGFR2 molecules in the plasma membrane. | 2.58e-05 | 2 | 177 | 2 | 29630862 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21679149 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 30804208 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 22393126 | ||
| Pubmed | Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. | 2.58e-05 | 2 | 177 | 2 | 18628209 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 2.58e-05 | 2 | 177 | 2 | 15388857 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 38092371 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 19857463 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23803732 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 11948691 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 15522955 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 GAPVD1 REXO4 ITSN1 POLR2A MUC19 PSMC1 PCARE IRS1 ARHGEF17 WIZ GTF3C1 TRIM9 AKAP13 | 2.69e-05 | 736 | 177 | 14 | 29676528 |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 2.77e-05 | 233 | 177 | 8 | 32290105 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | POLR2A KDM3B MUC16 CHD7 MLXIP ADAMTS12 FAT1 KMT2D NFIC ASXL3 ALDH3B2 MUC20 | 2.86e-05 | 552 | 177 | 12 | 10737800 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B REXO4 POLR2A NME2P1 RCC1 CHD7 RIF1 WIZ TRIM28 NUFIP2 ACIN1 SMARCC2 NME1 NME2 HSP90AA1 CBX2 | 3.27e-05 | 954 | 177 | 16 | 36373674 |
| Pubmed | ITSN1 CHD7 ARMCX4 PPP3CB WIZ TRIM28 KIAA1217 NUFIP2 PAK2 ANKRD17 SMARCC2 MACF1 RIMBP2 CEP131 WNK3 HSP90AA1 | 3.66e-05 | 963 | 177 | 16 | 28671696 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 4.54e-05 | 125 | 177 | 6 | 21654808 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNC REXO4 POLR2A RCC1 GPATCH8 RIF1 RBM22 GTF3C1 USP42 TRIM28 NFIC NUFIP2 ACIN1 SMARCC2 HSP90AA1 CBX2 | 5.01e-05 | 989 | 177 | 16 | 36424410 |
| Pubmed | 5.64e-05 | 15 | 177 | 3 | 29901792 | ||
| Pubmed | GAPVD1 ERCC2 IMPDH1 PSMC1 APEH CCDC77 FAT1 USP42 CASKIN2 MIB1 AKAP13 CEP131 CBX2 | 5.69e-05 | 689 | 177 | 13 | 36543142 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | DHX16 MYO9A POLR2A MUC16 GPATCH8 PTPDC1 PPP3CB KIAA1217 KDR CBX2 | 6.36e-05 | 420 | 177 | 10 | 28065597 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | REXO4 IMPDH1 PSMC1 RCC1 TSPYL1 CCDC77 RBM22 TRIM28 NUFIP2 PAK2 LRP4 SETD7 HSP90AA1 | 7.07e-05 | 704 | 177 | 13 | 32994395 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNC ACAA1 POLR2A MUC19 RCC1 MTAP TRIM28 SMARCC2 MACF1 AKAP13 ARHGAP18 NME1 PGM2 HSP90AA1 | 7.23e-05 | 807 | 177 | 14 | 30575818 |
| Pubmed | GAPVD1 ACAA1 IMPDH1 POLR2A APEH IRS1 RBM22 TRIM28 NUFIP2 MLH1 ACIN1 ANKRD17 SMARCC2 NME1 NME2 LEF1 MED13 HSP90AA1 | 7.30e-05 | 1247 | 177 | 18 | 27684187 | |
| Pubmed | SOX6 PDS5B KDM3B CITED1 ZCCHC14 RIF1 OVOL1 WIZ PER3 TRIM28 EIF2B2 ACIN1 LEF1 CBX2 | 7.32e-05 | 808 | 177 | 14 | 20412781 | |
| Interaction | TOP3B interactions | MPP3 FLNC ERCC2 HIVEP2 IMPDH1 POLR2A ZBTB4 KDM3B APEH RCC1 IRS1 MLXIP SPPL2B BAP1 GGT7 ZCCHC14 FAT1 MGAT1 KMT2D OVOL1 WIZ TRIM28 NUFIP2 MIB1 DIP2C LRP4 ACIN1 ANKRD17 AKAP13 CEP131 ZC3H7B MED13 HTT CBX2 | 1.44e-07 | 1470 | 176 | 34 | int:TOP3B |
| Interaction | YWHAG interactions | GAPVD1 DENND4A RIPOR2 HIVEP2 KAT5 MYO9A EXPH5 KDM3B IRS1 MLXIP ARHGEF17 MELK BAP1 ITPKB USP21 PTPDC1 CASKIN2 NUFIP2 PAK2 ACIN1 ANKRD17 MACF1 AKAP13 KDR CEP131 PLK4 HSP90AA1 HTT | 3.88e-06 | 1248 | 176 | 28 | int:YWHAG |
| Interaction | PER2 interactions | 8.17e-06 | 153 | 176 | 9 | int:PER2 | |
| Interaction | YWHAH interactions | GAPVD1 DENND4A HIVEP2 MYO9A EXPH5 KDM3B IRS1 MLXIP ARHGEF17 MELK BAP1 USP21 ZCCHC14 PTPDC1 CASKIN2 KIAA1217 PAK2 ANKRD17 MACF1 AKAP13 CEP131 PLK4 WNK3 HSP90AA1 HTT | 1.13e-05 | 1102 | 176 | 25 | int:YWHAH |
| Interaction | YWHAZ interactions | GAPVD1 DENND4A RIPOR2 HIVEP2 MYO9A EXPH5 IRS1 TACC2 MLXIP NEB MELK BAP1 USP21 PTPDC1 PPP3CB PPP3CC ASXL3 PAK2 ANKRD17 MACF1 AKAP13 CEP131 NME1 ALDH3A2 PLK4 HSP90AA1 HTT | 3.04e-05 | 1319 | 176 | 27 | int:YWHAZ |
| GeneFamily | ATP binding cassette subfamily A | 7.80e-05 | 14 | 111 | 3 | 805 | |
| GeneFamily | CD molecules|Mucins | 2.76e-04 | 21 | 111 | 3 | 648 | |
| GeneFamily | UDP glucuronosyltransferases | 9.81e-04 | 32 | 111 | 3 | 363 | |
| GeneFamily | NME/NM23 family | 1.31e-03 | 9 | 111 | 2 | 961 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.79e-03 | 13 | 111 | 2 | 693 | |
| GeneFamily | Fibronectin type III domain containing | 3.08e-03 | 160 | 111 | 5 | 555 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | SOX6 FLNC MUC16 IRS1 CHD7 CNTN6 PTK2B ASXL3 KIAA1217 LRP4 COL14A1 TMEM108 ALDH3A2 WNK3 | 1.56e-05 | 432 | 176 | 14 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 2.32e-05 | 69 | 176 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-08 | 184 | 176 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-08 | 184 | 176 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-08 | 184 | 176 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-07 | 200 | 176 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-07 | 176 | 176 | 8 | 2e3f25a338842384517656d05776a52cbfc62b52 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-07 | 176 | 176 | 8 | 0823088bc6b19c7ad784d83c2ccdfae80611afab | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 8.21e-07 | 187 | 176 | 8 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.76e-07 | 130 | 176 | 7 | c63f402d6ab71c2fcef12174b3139e55a727266c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.90e-07 | 189 | 176 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.26e-07 | 190 | 176 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-06 | 194 | 176 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-06 | 195 | 176 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-06 | 195 | 176 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.22e-06 | 197 | 176 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-06 | 198 | 176 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-06 | 200 | 176 | 8 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-06 | 110 | 176 | 6 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.65e-06 | 172 | 176 | 7 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.81e-06 | 177 | 176 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.81e-06 | 177 | 176 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-06 | 178 | 176 | 7 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.17e-06 | 182 | 176 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.17e-06 | 182 | 176 | 7 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 8.77e-06 | 184 | 176 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-06 | 185 | 176 | 7 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.09e-06 | 185 | 176 | 7 | 9d53e0a92e4f99370be2e4be1dd737630796b1ca | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-06 | 186 | 176 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 188 | 176 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Late_pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 188 | 176 | 7 | 1f24bb9cac5e74323ef93770442a869a89e07cf1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 176 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 190 | 176 | 7 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 191 | 176 | 7 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 192 | 176 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 193 | 176 | 7 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 193 | 176 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.20e-05 | 193 | 176 | 7 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 194 | 176 | 7 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 194 | 176 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 194 | 176 | 7 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 195 | 176 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 195 | 176 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-05 | 196 | 176 | 7 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-05 | 196 | 176 | 7 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.32e-05 | 196 | 176 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 197 | 176 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 198 | 176 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 198 | 176 | 7 | dd0465b45b02cb8edf0914d19afb52fcaaeb012c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.41e-05 | 198 | 176 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.46e-05 | 199 | 176 | 7 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.46e-05 | 199 | 176 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.51e-05 | 200 | 176 | 7 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.51e-05 | 200 | 176 | 7 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-05 | 200 | 176 | 7 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-05 | 139 | 176 | 6 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 4.70e-05 | 163 | 176 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.86e-05 | 164 | 176 | 6 | 2957065d7f1332c5280d47be7cc342286f84be3e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.86e-05 | 164 | 176 | 6 | 82e57d618c6e59bca4a03d31caf35b6043dfcf52 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 165 | 176 | 6 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.20e-05 | 166 | 176 | 6 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.56e-05 | 168 | 176 | 6 | 360cd756067c8cfb6a78301674758eb5fac52c23 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.56e-05 | 168 | 176 | 6 | d791116040a9d3ea0485d68c974340116073986b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-05 | 169 | 176 | 6 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-05 | 172 | 176 | 6 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-05 | 175 | 176 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.97e-05 | 175 | 176 | 6 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.42e-05 | 177 | 176 | 6 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.66e-05 | 178 | 176 | 6 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.66e-05 | 178 | 176 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 178 | 176 | 6 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.66e-05 | 178 | 176 | 6 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-05 | 179 | 176 | 6 | 7eca1e19ae6b5b1f18c721691dc3e860705628f2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-05 | 181 | 176 | 6 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.39e-05 | 181 | 176 | 6 | 7d7d1edeae4e0ebe40b324d1231cd26e27ba9d42 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.39e-05 | 181 | 176 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 182 | 176 | 6 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 182 | 176 | 6 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 182 | 176 | 6 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 182 | 176 | 6 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 182 | 176 | 6 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 182 | 176 | 6 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 182 | 176 | 6 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 182 | 176 | 6 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 182 | 176 | 6 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-05 | 183 | 176 | 6 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 8.92e-05 | 183 | 176 | 6 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-05 | 183 | 176 | 6 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-05 | 184 | 176 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-05 | 184 | 176 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 185 | 176 | 6 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 185 | 176 | 6 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 185 | 176 | 6 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 185 | 176 | 6 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 185 | 176 | 6 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 185 | 176 | 6 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.47e-05 | 185 | 176 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 185 | 176 | 6 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; HL60; HG-U133A | MPP3 CEP85 AAMDC EXPH5 ITSN1 SIRT6 ADAMTS12 CENPI DIP2C AKAP13 HTT | 4.76e-07 | 199 | 177 | 11 | 1432_UP |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; HL60; HG-U133A | ERCC2 RCC1 MLXIP BAP1 ADAMTS12 MTAP ACIN1 MACF1 AKAP13 ALDH3A2 HTT | 4.76e-07 | 199 | 177 | 11 | 2046_DN |
| Disease | Colorectal Neoplasms | FLNC ERCC2 ABCA4 ABCA10 FAT1 ABCA6 TRIM28 MLH1 KDR NME1 NME2 | 7.17e-07 | 277 | 171 | 11 | C0009404 |
| Disease | Colorectal Carcinoma | FLNC ERCC2 ABCA4 ABCA10 FAT1 ABCA6 KCND3 TRIM28 MLH1 DIP2C ACIN1 ZNF624 KDR NME1 NME2 LEF1 | 3.62e-06 | 702 | 171 | 16 | C0009402 |
| Disease | disease progression measurement | 2.82e-05 | 61 | 171 | 5 | EFO_0008336 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.01e-04 | 16 | 171 | 3 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.01e-04 | 16 | 171 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.01e-04 | 16 | 171 | 3 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.01e-04 | 16 | 171 | 3 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.01e-04 | 16 | 171 | 3 | C0025237 | |
| Disease | Van Buchem disease | 1.22e-04 | 17 | 171 | 3 | C0432272 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.35e-04 | 45 | 171 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | platelet component distribution width | MPP3 PDS5B GAPVD1 HIVEP2 TP53INP1 IRS1 SEC14L3 MEIOC SYTL4 PPP1R16B MLH1 PAK2 MACF1 AKAP13 | 1.38e-04 | 755 | 171 | 14 | EFO_0007984 |
| Disease | phosphatidylcholine 36:4 measurement | 1.46e-04 | 18 | 171 | 3 | EFO_0010382 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.65e-04 | 139 | 171 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 1.73e-04 | 19 | 171 | 3 | C0029422 | |
| Disease | Dyschondroplasias | 1.73e-04 | 19 | 171 | 3 | C0013366 | |
| Disease | Central Nervous System Neoplasms | 1.99e-04 | 4 | 171 | 2 | C0085136 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.03e-04 | 20 | 171 | 3 | C0026760 | |
| Disease | corneal hysteresis | 2.03e-04 | 20 | 171 | 3 | EFO_0010066 | |
| Disease | Intellectual Disability | GABRB2 HIVEP2 KDM3B L2HGDH ACIN1 SMARCC2 MACF1 ALDH3A2 MED13 HTT | 2.97e-04 | 447 | 171 | 10 | C3714756 |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 3.30e-04 | 5 | 171 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | teratoma (is_implicated_in) | 3.30e-04 | 5 | 171 | 2 | DOID:3307 (is_implicated_in) | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 3.54e-04 | 24 | 171 | 3 | DOID:1184 (implicated_via_orthology) | |
| Disease | diverticular disease | 4.73e-04 | 236 | 171 | 7 | EFO_0009959 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 4.93e-04 | 6 | 171 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | macular degeneration (is_implicated_in) | 5.05e-04 | 27 | 171 | 3 | DOID:4448 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ABCA4 TACC2 MSI1 CNTN6 BAP1 ZCCHC14 RIF1 KMT2D PER3 DIP2C MACF1 KDR KLHDC7A LEF1 MAP2K7 HSP90AA1 | 5.40e-04 | 1074 | 171 | 16 | C0006142 |
| Disease | nucleoside diphosphate kinase B measurement | 6.88e-04 | 7 | 171 | 2 | EFO_0020615 | |
| Disease | uric acid measurement | FAT4 MYO9A STK32B ZBTB4 MLXIP GGT7 PTPDC1 OVOL1 ABCA6 DIP2C AKAP13 | 9.06e-04 | 610 | 171 | 11 | EFO_0004761 |
| Disease | Attached earlobe | 9.14e-04 | 8 | 171 | 2 | HP_0009907 | |
| Disease | retinal vasculature measurement | DHX16 SOX6 PDS5B IL20RB NCKAP5 FZD6 PTK2B ACIN1 RIMBP2 DNAH5 | 9.15e-04 | 517 | 171 | 10 | EFO_0010554 |
| Disease | Prostatic Neoplasms | 9.80e-04 | 616 | 171 | 11 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.80e-04 | 616 | 171 | 11 | C0376358 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.17e-03 | 9 | 171 | 2 | EFO_0600040 | |
| Disease | uveal melanoma (is_marker_for) | 1.17e-03 | 9 | 171 | 2 | DOID:6039 (is_marker_for) | |
| Disease | testosterone measurement | SOX6 DENND4A KAT5 POLR2A ZBTB4 CHD7 OVOL1 PER3 SYTL4 NUFIP2 UGT2B7 MACF1 RIMBP2 UGT2B11 LEF1 MAP2K7 IGSF23 | 1.23e-03 | 1275 | 171 | 17 | EFO_0004908 |
| Disease | Bladder Neoplasm | 1.37e-03 | 140 | 171 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.41e-03 | 141 | 171 | 5 | C0005684 | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 1.46e-03 | 10 | 171 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | age at onset, multiple sclerosis | 1.46e-03 | 10 | 171 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 1.77e-03 | 11 | 171 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | placenta growth factor measurement | 1.77e-03 | 11 | 171 | 2 | EFO_0010626 | |
| Disease | Proteinuria | 1.99e-03 | 43 | 171 | 3 | C0033687 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 1.99e-03 | 43 | 171 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | mean corpuscular hemoglobin concentration | SOX6 PDS5B DENND4A ITSN1 POLR2A NEB RIF1 ABCA6 KIAA1217 PAK2 MACF1 AKAP13 MAP2K7 PLK4 MED13 | 2.01e-03 | 1105 | 171 | 15 | EFO_0004528 |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 2.12e-03 | 12 | 171 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 2.12e-03 | 12 | 171 | 2 | C0270960 | |
| Disease | concentration of large LDL particles measurement | 2.13e-03 | 44 | 171 | 3 | EFO_0022160 | |
| Disease | schizophrenia (is_marker_for) | 2.13e-03 | 44 | 171 | 3 | DOID:5419 (is_marker_for) | |
| Disease | age at diagnosis, osteonecrosis | 2.13e-03 | 44 | 171 | 3 | EFO_0004259, EFO_0004918 | |
| Disease | cholesterol in medium VLDL measurement | 2.13e-03 | 44 | 171 | 3 | EFO_0022225 | |
| Disease | Skin Abnormalities | 2.50e-03 | 13 | 171 | 2 | C0037268 | |
| Disease | X-19141 measurement | 2.50e-03 | 13 | 171 | 2 | EFO_0800799 | |
| Disease | mean platelet volume | MPP3 PDS5B HIVEP2 AAMDC PCDHGA6 POLR2A IRS1 CHD7 MEIOC SYTL4 PPP1R16B ARHGAP18 ALDH3A2 HTT | 2.56e-03 | 1020 | 171 | 14 | EFO_0004584 |
| Disease | malignant pleural mesothelioma (is_marker_for) | 2.90e-03 | 14 | 171 | 2 | DOID:7474 (is_marker_for) | |
| Disease | Situs ambiguus | 3.34e-03 | 15 | 171 | 2 | C0266642 | |
| Disease | urinary bladder cancer (is_marker_for) | 3.54e-03 | 107 | 171 | 4 | DOID:11054 (is_marker_for) | |
| Disease | T-Cell Lymphoma | 3.80e-03 | 16 | 171 | 2 | C0079772 | |
| Disease | Abnormal behavior | 3.80e-03 | 16 | 171 | 2 | C0233514 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 4.23e-03 | 56 | 171 | 3 | EFO_0022250 | |
| Disease | Huntington Disease | 4.29e-03 | 17 | 171 | 2 | C0020179 | |
| Disease | Alzheimer disease, brain volume measurement | 4.29e-03 | 17 | 171 | 2 | EFO_0006930, MONDO_0004975 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.52e-03 | 264 | 171 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | breast cancer (is_marker_for) | 4.56e-03 | 185 | 171 | 5 | DOID:1612 (is_marker_for) | |
| Disease | Alcoholic Intoxication, Chronic | 4.85e-03 | 268 | 171 | 6 | C0001973 | |
| Disease | cancer (implicated_via_orthology) | 4.85e-03 | 268 | 171 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | colon cancer (is_marker_for) | 4.90e-03 | 59 | 171 | 3 | DOID:219 (is_marker_for) | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 5.35e-03 | 19 | 171 | 2 | C0751884 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 5.35e-03 | 19 | 171 | 2 | DOID:4928 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSRKMGTPSSLATGI | 226 | Q6UXB8 | |
| PEAVGTDPSTSRKMA | 46 | Q9UKV3 | |
| VIGRGMSEALKVPSS | 66 | Q9H7C9 | |
| TGPMEDTASKREDGS | 956 | Q5RHP9 | |
| KGQRRMSDPESVSSV | 471 | Q86WK6 | |
| MTSEKGPSTGDPTLR | 1 | P41238 | |
| KGRTVIGTPDEETMD | 11 | Q8WWZ4 | |
| IMNVSGGPITREASK | 1586 | P78363 | |
| TVSEGEVMENKRPGT | 3511 | Q6V0I7 | |
| RMISGITKPTAGEVE | 1331 | Q8N139 | |
| RNEETGTKSSGMPTD | 421 | Q12802 | |
| GPTKRRGMADSLEST | 26 | Q9BR77 | |
| ATDSREKTGMVRPGE | 606 | Q92560 | |
| IKRMIDETSSGGVTG | 371 | P51648 | |
| TGSPRVGKIVMTAAT | 106 | P48448 | |
| RAKTGLTPLMEAASG | 1281 | O75179 | |
| GELTTSGRKMAELPV | 806 | O60231 | |
| DAEGPVVEKIMSSRS | 796 | Q9P2D1 | |
| SQGETLPGARDKSMS | 1036 | Q5H9R4 | |
| STPETKMEGSTGVII | 1146 | Q9C0F0 | |
| TLTKGPEMEIHSGSG | 1146 | P58397 | |
| GKISGESMESTPELL | 976 | Q7Z401 | |
| RDTSVEGSEMVPGKV | 101 | P18754 | |
| TRPVGMLGKATSTSD | 131 | Q9NW64 | |
| SPGRIKGRLDSSEMD | 1166 | Q9NTI5 | |
| KGTMVTIEGPRFSSR | 166 | Q13126 | |
| PRDTMAKESSIIGVT | 256 | Q08257 | |
| EKLQESASGTGPRMT | 381 | Q9UJU2 | |
| STGTDKLMTGVISPE | 486 | Q14680 | |
| TGRVMLGETNPADSK | 86 | P22392 | |
| KTGLPATSAMDEGLT | 766 | Q96PE2 | |
| SGVEVESSMGPSLLL | 231 | Q9NZ53 | |
| RAVDGGMPTLSSDVI | 2361 | Q14517 | |
| GKTTDMSRISLEPGT | 4201 | Q8WXI7 | |
| GMPTGATTKVSRTEA | 8731 | Q8WXI7 | |
| SLDDMEKISRGPTGR | 786 | O60500 | |
| VLTAMDGGDPVRSSV | 211 | Q9Y5G7 | |
| LTGTPEEEHMGKTTS | 456 | Q9UK17 | |
| TDSLPMIVSIKEGGR | 321 | O75610 | |
| PEISRTMTFGRKGVS | 306 | P26572 | |
| GIEMAKESPSRSIDG | 221 | Q9H9P8 | |
| TMDIATKGPFPTSRD | 591 | Q8N307 | |
| EMILAPEGSSSGKLR | 736 | Q8NDA2 | |
| GSEKVAATGSRGELM | 266 | Q96FN5 | |
| LAMTGSEEGDPRTKS | 351 | Q14C86 | |
| LMGLKSESGERPQIT | 426 | Q92993 | |
| KRKGSDSDPSQSGIM | 51 | Q8WYA1 | |
| KIVRSSGGRMDAPAS | 621 | Q9UKJ3 | |
| KSEMPTNGRSIDTGG | 596 | P56645 | |
| EMGSQDGSPLRETRK | 76 | Q9UJ14 | |
| DVMAKTESPRTSGVL | 396 | O14733 | |
| APGIKTDIMGESSRT | 7631 | Q7Z5P9 | |
| GELTGEVRMPSGKTA | 1796 | Q14315 | |
| KEIIGGTSESEPMLS | 66 | Q5W0B1 | |
| NGGVATMRTSGTEPK | 551 | Q96G03 | |
| GSSVDRKVPAESMPT | 586 | Q7LBC6 | |
| TRMESQLSASKPTGG | 2476 | O94854 | |
| EMPSGTGKTVSLLAL | 41 | P18074 | |
| REGRKKPLTSGMDAS | 1136 | Q8NEV8 | |
| ATSEAVMGLGDPRST | 416 | P47870 | |
| IGSKTRMAESTGPEP | 1661 | Q6ZVL6 | |
| LSMSTRAIRPTEEGG | 56 | Q6UWW0 | |
| SEGPGLSAEIEKTMS | 311 | A2A3K4 | |
| ESITATSPASMVGGK | 306 | P35568 | |
| PKEVMSPTGSARGRS | 186 | O43347 | |
| SRMTPEDLTAIGVTK | 521 | Q8WXE0 | |
| TILTRPGMEITKDGF | 136 | Q6UXL0 | |
| LMPKDGKSTATDITG | 141 | A6NI72 | |
| LMPKDGKSTATDITG | 116 | A8MVU1 | |
| LRTKMKVTLGDSPSG | 101 | O14753 | |
| DGERKLCTPSMDTTG | 456 | P78509 | |
| ETGTMGSKLVGIVTS | 146 | P20839 | |
| KVSGQVGSRSPSMIS | 796 | Q86YT6 | |
| KTPGRIRSSSGILSM | 231 | O14786 | |
| MARTGESSSEGKAPL | 506 | Q96T49 | |
| SGPLKREGMLASTVS | 591 | Q9HAP2 | |
| VRMSSTIFSTGGKDP | 16 | Q13177 | |
| TSPETSMREVKADGA | 591 | O60353 | |
| GSFGVTRKEMEVSPS | 336 | P42858 | |
| TTTTDPMLEKDAAGG | 21 | A1L1A6 | |
| LIGASGATMPTDTSK | 396 | Q14781 | |
| VESSMPEDRKSSTPG | 1746 | Q13698 | |
| ERSESGGKIMTPESL | 281 | Q6ZN84 | |
| SEGLRGTETTLALPM | 431 | Q05707 | |
| GPIRKSTSMDSGSSE | 971 | Q15811 | |
| SKLPLSGLAESVGMT | 116 | Q6P2H3 | |
| MSLGGASERSVPATK | 1 | Q8IYJ1 | |
| LMETGDGVPVSSRVS | 241 | Q9Y2E4 | |
| GDGSSSEEIRIPKMS | 981 | Q9UQ52 | |
| MGLRASGKDSAPTVV | 41 | Q9HBG7 | |
| PTGGSKDRTAEMVAV | 661 | Q5VTJ3 | |
| EMAASLKRPDSGATG | 776 | P20849 | |
| TVRTDTGEPMGRGTK | 171 | P07900 | |
| MPGSAAKGSELSERI | 1 | P49770 | |
| MSGVSEPLSRVKLGT | 1 | Q14289 | |
| PLETTLGGSMNSVSK | 521 | Q92674 | |
| LDTVPMTGTKSGNEI | 581 | Q86UP8 | |
| LDTVPMTGTKSGNEI | 581 | Q6EKJ0 | |
| SESVLTLKGLTPTGM | 426 | P16298 | |
| MSGRVGDLSPKQAET | 1 | Q9UDX4 | |
| GPLELGSEVSTSVMR | 561 | Q9UPN4 | |
| MLPKTSGTRATSLGR | 101 | P36551 | |
| KGSLMTGRSERSQPT | 1046 | Q8TDX9 | |
| PAGTGKTETTKDMGR | 1981 | Q8TE73 | |
| MGSDPTDSIIALGKR | 4051 | Q8TE73 | |
| RKDMEGLIPGTKTSS | 86 | A6NGG8 | |
| EGKMSSGAESPELLT | 356 | Q13368 | |
| VVIGTKDTMSTGLTG | 546 | Q96Q06 | |
| EASRGSVPSGSKMDR | 126 | Q9GZR2 | |
| GDRSKSVPGLNVDME | 291 | Q96C24 | |
| TPQTGLSDIMKESGV | 271 | A2RUB1 | |
| GTPVSTTVAKAMARE | 661 | O15034 | |
| EGIRPSTTMEGLAKL | 246 | P09110 | |
| GESSIMSEIRGKPIE | 136 | Q9Y519 | |
| KSGDTTLGPERAMSP | 966 | Q7Z7B0 | |
| LEMTSSKSVSPGRKG | 1076 | O14513 | |
| TGRVMLGETNPADSK | 86 | P15531 | |
| LTLTSRMTGEEGKEV | 31 | Q5UIP0 | |
| TAMEIDKRGSPTPGT | 271 | P27987 | |
| TGRVMLGETNPADSK | 71 | O60361 | |
| EPLSRTGSQEGTSME | 586 | Q8IV36 | |
| EKMTGGVTSELPETE | 251 | Q8TE76 | |
| TTSEKINMISGPKRG | 146 | Q99909 | |
| GPRSSKEILGMQTSE | 71 | Q5T5P2 | |
| EGKLATLMSTEEGRP | 166 | Q8WTS6 | |
| GVGKREEIMITSEPS | 446 | Q9BZQ2 | |
| VKSGRDMGDPSGLVS | 271 | Q8N5S1 | |
| DTPKTLDMAVVGGRE | 176 | O95785 | |
| TMDRDKVGIPTDGDS | 1616 | Q9UHV7 | |
| RSKVDDLRGTPMSVG | 96 | P62191 | |
| TTKGTSEMSEKRGPT | 451 | P40692 | |
| RTGMGSDQEDSKPIT | 196 | P08651 | |
| SAEMLSVSKRSGGGE | 401 | O00444 | |
| DTVVGTMGLKATGRL | 151 | Q8N6T7 | |
| DSESAPVKGGTMTDL | 366 | Q8TAQ2 | |
| VPMATDRLLSEGSVG | 576 | Q9Y4F9 | |
| IMTSVTFGTPERRKG | 111 | P35712 | |
| ESPSGTMKAVLRKAG | 96 | P13798 | |
| MPTTSRPALDVKGGT | 1 | Q99966 | |
| GGMSPEITSLDDIRK | 196 | P48454 | |
| STLSREGKPEGEIMA | 6 | Q9P2J8 | |
| LKGSTDEMSAPGAER | 726 | Q9H9J4 | |
| SKSVSSGDLRPMGIA | 111 | Q9UK80 | |
| VGDMLRKSSDSKPGV | 296 | Q7Z417 | |
| MAGRSLTSKAEPTAG | 1 | Q8N0S2 | |
| MSGLDGVKRTTPLQT | 1 | Q9H0U9 | |
| AVMSDRVPDSIVKGT | 1151 | Q96PX9 | |
| LSPDELKRMSVTEGG | 26 | P24928 | |
| AGGLTTIKVETSPME | 106 | Q96A56 | |
| KSGSSIMVEVATGPS | 371 | Q8TCT7 | |
| DTSPFRSGTPMKEAV | 261 | Q96FX7 | |
| ASGKPEMRLGTQEET | 16 | Q86VQ3 | |
| SPDTTAMDTGTKEAG | 106 | Q9Y6L7 | |
| AGPAMATTTEEAKGR | 546 | Q9P1Z0 | |
| EPGSSSRESVSKAGM | 436 | O95359 | |
| GRPTTLFETMGKADI | 241 | O75310 | |
| TGTTRIGDLAPQDMK | 271 | Q8N392 | |
| ETGRSGATKMPRVTC | 2356 | Q96JG9 | |
| GKGTLTPRMTTDFDL | 401 | Q9C026 | |
| PSLSKVGTVMGVSGR | 216 | Q8WYQ9 | |
| MDEVSSVSVGPLGSL | 691 | P98168 | |
| APMTEIKELTGSTGQ | 111 | P17035 | |
| VKGAERASSMAGTKP | 171 | Q9NY57 | |
| TLEDRTKLSPSFGGM | 1271 | P35968 | |
| GRPTTLFETMGKADI | 241 | Q9BY64 | |
| GRPTTLSETMGKADV | 241 | P16662 | |
| GETDAEGTQMTPAKR | 1871 | Q12789 | |
| SVATLGGSKRMLSPA | 1431 | P31629 | |
| SGSGSVSIRKPASEM | 326 | Q9UPU7 | |
| PSGVTMERAGLGEKS | 151 | Q96PQ6 | |
| MVTVGKSSDGTPDRR | 761 | Q9HBA0 | |
| SRSGEGEVSGLMRKV | 471 | Q13263 | |
| AMATTSSKPEGRPRG | 121 | Q6UXF1 | |
| GSTRGSLDKPDSFME | 366 | Q9UGR2 | |
| EEAEMKAVATSPSGR | 131 | Q9BYP7 | |
| PGEGMLSSDLDRIST | 1866 | O14686 | |
| GSNMETVIGRGLKTT | 1416 | O75096 | |
| KTKETPEGTVMSGRR | 2511 | B2RTY4 | |
| ESDRKSVVGLLSGGM | 11 | Q9UHF3 | |
| SIRGKGLTEMEDTPD | 5981 | P20929 |